English

慶應義塾大学  薬学部  薬学科

助教  市川 大樹  イチカワ ダイジュ  ICHIKAWA Daiju

■ 研究業績(原著論文・解説) 研究論文（学術雑誌）  共著  NLR Nod1 signaling promotes survival of BCR-engaged mature B cells through up-regulated Nod1 as a positive outcome.  市川 大樹  J Exp Med.  2017/09/06  10.1084/jem.20170497  研究論文（学術雑誌）  共著  A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.  市川 大樹  Biochem Biophys Res Commun.  2017/09/01  10.1016/j.bbrc.2017.08.159  研究論文（学術雑誌）  共著  Synthesis and biological evaluation of the natural product komaroviquinone and related compounds aiming at a potential therapeutic lead compound for high-risk multiple myeloma.  市川 大樹  2017/08/30  10.1016/j.bmcl.2017.08.054  研究論文（学術雑誌）  共著  Early generated B1 B cells with restricted BCRs become chronic lymphocytic leukemia with continued c-Myc and low Bmf expression.  市川 大樹  J Exp Med  213/ 13, 3007-3024  2016/12/12  研究論文（学術雑誌）  共著  Identification of Novel HLA-A*24:02-Restricted Epitope Derived from a Homeobox Protein Expressed in Hematological Malignancies  市川 大樹  PLOS ONE  11/ 1  2016/01  1932-6203  10.1371/journal.pone.0146371  詳細表示...   ■ 研究業績(口頭・ポスター発表) ポスター発表  Komaroviquinone-Derivatives, Revealed Anti-Tumor Effect on High-Risk Multiple Myeloma Cells In Vitro as Well as In Vivo  ASH, 58th Annual Meeting & Exposition  2016/12/03  口頭発表（一般）  Structural optimization and anti-tumor activities of komaroviquinone to high-risk myeloma  第78回日本血液学会学術集会  2016/10/13  ポスター発表  ハイリスク多発性骨髄腫に対する新規komaroviquinone誘導体による克服薬の開発  第41回日本骨髄腫学会学術集会  2016/05/29  ポスター発表  Drug Design for Overcoming High-Risk Myeloma and Identification of Novel Binding Proteins to Immune-Modulatory Drugs  57th Annual Meeting and Exposition  2015/12/05  ポスター発表  Monitoring of immunity against leukemia stem cell in CML patients after cessation of TKI.  30th Annual Meeting of The Society for Immunotherapy of Cancer（SITC）  2015/11/05  詳細表示...